RUNX1 Research Grants

Our roadmap is simple. We only invest in research that brings us one step closer to our end goal. We understand that discovering medicines requires the right tools (i.e. disease models and laboratory reagents) and the right datasets (i.e. patient clinical and genomic data, as well as patient biospecimens). We have defined 4 rational therapeutic approaches to preventing blood cancer:

1) selectively targeting precancerous cells;

2) increasing RUNX1 activity;

3) decreasing cancer-causing inflammation;

4) fixing or replacing RUNX1-mutated cells using cell or gene therapy.